Case Study 1 — A Researcher Meets the Ecosystem

This case is a composite, created for teaching. Dr. Hernandez and her project are illustrative and do not depict a real person or study. She recurs throughout this book as one of our anchor examples; the NIH structures referenced are real but simplified, and you should always verify current details with the agency.

The Situation

Dr. Maya Hernandez is a newly independent behavioral scientist at a mid-size research university. For three years she has been developing a simple idea with surprisingly strong early results: a text-message system that sends adults with Type 2 diabetes tailored medication reminders plus brief feedback on their glucose readings. In a small pilot of about forty patients, the people who got the texts took their medication more reliably and showed better blood-sugar control than those who did not.

Maya knows this is fundable work. What she does not yet know is who would fund it, as what, and why. She has a folder of pilot data, a head full of ideas, and a dangerous instinct: to write one excellent proposal describing her project and send it wherever she sees grant money.

Applying the Chapter

Which river? Maya's work is research — testing a hypothesis to create new knowledge — so the most plausible river is federal agencies, and within that, the NIH, the world's largest biomedical funder. (A diabetes-focused foundation is a second possibility we will hold for later.) Already the ecosystem map has narrowed her field from "anyone with money" to "the agency whose mission is biomedical research."

Which institute, and the mission transaction. Here is where the chapter's central reframe does real work. The NIH is not one funder; it is a federation of institutes, each with its own mission. Maya's project could plausibly fit the institute focused on diabetes and digestive and kidney diseases — if she frames it as advancing that institute's mission to improve diabetes outcomes. The same project could fit an institute focused on behavioral or nursing science if framed around adherence behavior, or one focused on minority health if her population and design centered health disparities. The project does not change; the mission transaction does. The fatal move would be to write a project-centered proposal ("here is my clever text-message system") and let the reader guess which mission it serves. The winning move is to choose the institute whose mission her work most genuinely advances and frame the entire proposal as a way to accomplish that mission.

Which grant type and mechanism. Maya's project is research, and as an early-stage investigator with promising but limited pilot data, she faces a strategic choice we will develop fully in Chapters 16 and 27: a smaller, exploratory mechanism to build more evidence, or a full-scale project grant now. The ecosystem gives her options; her evidence and career stage should drive the choice, not her ambition alone.

What Goes Wrong (and Why)

Imagine Maya ignores all of this and submits a forty-page, project-centered proposal to a single institute, two weeks before the deadline, without calling anyone. Trace the failure patterns from the chapter:

  • Misalignment risk: she picked the institute by guesswork, not by mission fit.
  • Unclear ask risk: without a mission frame, the reviewer struggles to say in one sentence why this institute should fund this now.
  • Late-start risk: two weeks is not enough to align, get feedback, or build a careful budget.
  • No relationship: she never spoke to a program officer who could have told her, in fifteen minutes, whether the project fit and which mechanism to use.

This is almost exactly the situation that opened the chapter — good science, triaged. None of it was caused by the quality of her work.

The Better Path

Maya instead spends her first weeks not writing but mapping: identifying the institute whose mission her work advances, drafting a one-paragraph mission-transaction framing (Chapter 2's skill), and emailing a program officer to ask whether the project fits and which mechanism suits an early-stage investigator. Only then does she begin to write — months before the deadline. She has not yet written a better proposal. She has done something more important: she has positioned an ordinary proposal to win.

Discussion Questions

  1. The same project could fit several NIH institutes. Is choosing among them "gaming the system," or is it a legitimate act of alignment? Where is the line between honest reframing and dishonest shoehorning?
  2. Maya's pilot has only ~40 patients. How might that shape which grant type or mechanism she should pursue first?
  3. What is the single highest-value thing Maya could do before writing a word, and why does it beat simply writing a stronger draft?